Skip to main content
Gilead's Truvada approved for adolescents

Gilead Sciences' Truvada, or emtricitabine/TDF, together with safer sex practices was approved by the FDA for adolescents who are at risk of acquiring sexually transmitted HIV-1 infection. The drug was previously approved in 2012 as a pre-exposure prophylaxis in adults.

Full Story: